ディオズゲニンは,アポトーシス誘導,G2/M細胞サイクル停止,ROS生成を通じて,頭頸がん細胞に対する放射線の効果を高める
Mohadeseh Mohammadi1, Fereshteh Koosha2, Seyed Mohammad Amini3
1Department of Radiology Technology, Faculty of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Darband St, Ghods Sq., Tehran, Iran.
Medical oncology (Northwood, London, England)
|September 3, 2025
まとめ
ディオズゲニンは,がん細胞死とアポトーシスを増加させることで,頭頸がんの放射線治療を強化します. この天然の化合物は 放射線治療の補助剤として 有望な効果を示しており 正常な細胞では毒性が低下しています
科学分野:
- 腫瘍学
- 癌 研究
- 薬理学について
背景:
- 放射線治療は,頭頸部がんの主要な治療法です.
- 腫瘍の低酸素と癌の幹細胞により,治療の有効性はしばしば損なわれます.
- ディオズゲニンは 潜在的治療用途を持つ天然化合物です
研究 の 目的:
- 頭頸部がん細胞におけるディオスゲニンの放射線感受性を調査する.
- 癌細胞の生存能力,アポトーシス,および関連する分子経路に対する放射線と結合したディオスゲニンの効果を評価する.
- ガン細胞に対するディオスゲニンの毒性の違いと,正常な細胞に対する毒性の違いを評価する.
主な方法:
- KB頭頸部がん細胞と正常なヒト皮膚線維芽細胞 (HDF) はディオスゲニンおよび/または4GYX線で治療された.
- 細胞活性はMTTアッセイを用いて評価された.
- アポトーシス,細胞サイクル分布,活性酸素種 (ROS) 生成,遺伝子発現 (Bax/ Bcl-2比) はフローサイトメトリとRT- qPCRで分析された.
主要な成果:
- ディオズゲニンは単独でKB細胞の生存率を低下させ,放射線治療と併用すると,単独治療と比較してさらに生存率を著しく低下させた (p < 0. 05).
- ディオズゲニンは正常なHDF細胞では毒性が低い.
- 放射線誘発によるアポトーシス,G2/M停止,サブG1蓄積,ROS産生を拡大した.
- 本質的なアポプトシス経路の活性化を示すバックス/ Bcl-2 mRNA比の有意な増加が観察されました (p < 0. 0001).
結論:
- ディオズゲニンは放射線敏感剤として作用し,頭頸部がん細胞に対する放射線療法の有効性を高めます.
- ディオスゲニンと放射線療法の組み合わせは,アポトーシスを効果的に誘導し,癌細胞の生存能力を低下させます.
- ディオズゲニンは,頭頸部がんの放射線治療に安全で効果的な補助剤として潜在性を示しています.
関連する概念動画
DNA Damage can Stall the Cell Cycle
9.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
Mutations
39.7K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
39.7K
Negative Regulator Molecules
35.9K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.9K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K


